Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP615785.RAWCFTFZ9OiFgVVMyhQiXJUd0tKOEtJ4cgtigUDcKcxyk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615785.RAWCFTFZ9OiFgVVMyhQiXJUd0tKOEtJ4cgtigUDcKcxyk130_assertion type Assertion NP615785.RAWCFTFZ9OiFgVVMyhQiXJUd0tKOEtJ4cgtigUDcKcxyk130_head.
- NP615785.RAWCFTFZ9OiFgVVMyhQiXJUd0tKOEtJ4cgtigUDcKcxyk130_assertion description "[However, as GAGs inhibit OPG 1-401 but not OPG 1-194 binding to TRAIL or to RANKL, they may represent potent regulators of OPG availability and antitumor activity in bone tumor microenvironment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615785.RAWCFTFZ9OiFgVVMyhQiXJUd0tKOEtJ4cgtigUDcKcxyk130_provenance.
- NP615785.RAWCFTFZ9OiFgVVMyhQiXJUd0tKOEtJ4cgtigUDcKcxyk130_assertion evidence source_evidence_literature NP615785.RAWCFTFZ9OiFgVVMyhQiXJUd0tKOEtJ4cgtigUDcKcxyk130_provenance.
- NP615785.RAWCFTFZ9OiFgVVMyhQiXJUd0tKOEtJ4cgtigUDcKcxyk130_assertion SIO_000772 19147566 NP615785.RAWCFTFZ9OiFgVVMyhQiXJUd0tKOEtJ4cgtigUDcKcxyk130_provenance.
- NP615785.RAWCFTFZ9OiFgVVMyhQiXJUd0tKOEtJ4cgtigUDcKcxyk130_assertion wasDerivedFrom befree-20140225 NP615785.RAWCFTFZ9OiFgVVMyhQiXJUd0tKOEtJ4cgtigUDcKcxyk130_provenance.
- NP615785.RAWCFTFZ9OiFgVVMyhQiXJUd0tKOEtJ4cgtigUDcKcxyk130_assertion wasGeneratedBy ECO_0000203 NP615785.RAWCFTFZ9OiFgVVMyhQiXJUd0tKOEtJ4cgtigUDcKcxyk130_provenance.